397 related articles for article (PubMed ID: 12878516)
1. Correlation of daptomycin bactericidal activity and membrane depolarization in Staphylococcus aureus.
Silverman JA; Perlmutter NG; Shapiro HM
Antimicrob Agents Chemother; 2003 Aug; 47(8):2538-44. PubMed ID: 12878516
[TBL] [Abstract][Full Text] [Related]
2. Consequences of daptomycin-mediated membrane damage in Staphylococcus aureus.
Hobbs JK; Miller K; O'Neill AJ; Chopra I
J Antimicrob Chemother; 2008 Nov; 62(5):1003-8. PubMed ID: 18669516
[TBL] [Abstract][Full Text] [Related]
3. Daptomycin disrupts membrane potential in growing Staphylococcus aureus.
Alborn WE; Allen NE; Preston DA
Antimicrob Agents Chemother; 1991 Nov; 35(11):2282-7. PubMed ID: 1666494
[TBL] [Abstract][Full Text] [Related]
4. Bactericidal action of daptomycin against stationary-phase and nondividing Staphylococcus aureus cells.
Mascio CT; Alder JD; Silverman JA
Antimicrob Agents Chemother; 2007 Dec; 51(12):4255-60. PubMed ID: 17923487
[TBL] [Abstract][Full Text] [Related]
5. Transcriptional profiling reveals that daptomycin induces the Staphylococcus aureus cell wall stress stimulon and genes responsive to membrane depolarization.
Muthaiyan A; Silverman JA; Jayaswal RK; Wilkinson BJ
Antimicrob Agents Chemother; 2008 Mar; 52(3):980-90. PubMed ID: 18086846
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms of resistance to daptomycin in Staphylococcus aureus.
Gómez Casanova N; Siller Ruiz M; Muñoz Bellido JL
Rev Esp Quimioter; 2017 Dec; 30(6):391-396. PubMed ID: 29082727
[TBL] [Abstract][Full Text] [Related]
7. Daptomycin exerts bactericidal activity without lysis of Staphylococcus aureus.
Cotroneo N; Harris R; Perlmutter N; Beveridge T; Silverman JA
Antimicrob Agents Chemother; 2008 Jun; 52(6):2223-5. PubMed ID: 18378708
[TBL] [Abstract][Full Text] [Related]
8. Antibacterial mechanism of daptomycin antibiotic against Staphylococcus aureus based on a quantitative bacterial proteome analysis.
Ma W; Zhang D; Li G; Liu J; He G; Zhang P; Yang L; Zhu H; Xu N; Liang S
J Proteomics; 2017 Jan; 150():242-251. PubMed ID: 27693894
[TBL] [Abstract][Full Text] [Related]
9. Daptomycin exerts rapid bactericidal activity against Bacillus anthracis without disrupting membrane integrity.
Xing YH; Wang W; Dai SQ; Liu TY; Tan JJ; Qu GL; Li YX; Ling Y; Liu G; Fu XQ; Chen HP
Acta Pharmacol Sin; 2014 Feb; 35(2):211-8. PubMed ID: 24362329
[TBL] [Abstract][Full Text] [Related]
10. Impact of Bacterial Membrane Fatty Acid Composition on the Failure of Daptomycin To Kill Staphylococcus aureus.
Boudjemaa R; Cabriel C; Dubois-Brissonnet F; Bourg N; Dupuis G; Gruss A; Lévêque-Fort S; Briandet R; Fontaine-Aupart MP; Steenkeste K
Antimicrob Agents Chemother; 2018 Jul; 62(7):. PubMed ID: 29735564
[TBL] [Abstract][Full Text] [Related]
11. The action mechanism of daptomycin.
Taylor SD; Palmer M
Bioorg Med Chem; 2016 Dec; 24(24):6253-6268. PubMed ID: 27288182
[TBL] [Abstract][Full Text] [Related]
12. Daptomycin pharmacodynamics against Staphylococcus aureus hemB mutants displaying the small colony variant phenotype.
Begic D; von Eiff C; Tsuji BT
J Antimicrob Chemother; 2009 May; 63(5):977-81. PubMed ID: 19304733
[TBL] [Abstract][Full Text] [Related]
13. Mechanism of action and limited cross-resistance of new lipopeptide MX-2401.
Rubinchik E; Schneider T; Elliott M; Scott WR; Pan J; Anklin C; Yang H; Dugourd D; Müller A; Gries K; Straus SK; Sahl HG; Hancock RE
Antimicrob Agents Chemother; 2011 Jun; 55(6):2743-54. PubMed ID: 21464247
[TBL] [Abstract][Full Text] [Related]
14. Development of Daptomycin resistance in vivo in methicillin-resistant Staphylococcus aureus.
Hayden MK; Rezai K; Hayes RA; Lolans K; Quinn JP; Weinstein RA
J Clin Microbiol; 2005 Oct; 43(10):5285-7. PubMed ID: 16207998
[TBL] [Abstract][Full Text] [Related]
15. In vitro bactericidal activities of daptomycin against Staphylococcus aureus and Enterococcus faecalis are not mediated by inhibition of lipoteichoic acid biosynthesis.
Laganas V; Alder J; Silverman JA
Antimicrob Agents Chemother; 2003 Aug; 47(8):2682-4. PubMed ID: 12878541
[TBL] [Abstract][Full Text] [Related]
16. In vitro activities of daptomycin, arbekacin, vancomycin, and gentamicin alone and/or in combination against glycopeptide intermediate-resistant Staphylococcus aureus in an infection model.
Akins RL; Rybak MJ
Antimicrob Agents Chemother; 2000 Jul; 44(7):1925-9. PubMed ID: 10858356
[TBL] [Abstract][Full Text] [Related]
17. Clinical progression of methicillin-resistant Staphylococcus aureus vertebral osteomyelitis associated with reduced susceptibility to daptomycin.
Vikram HR; Havill NL; Koeth LM; Boyce JM
J Clin Microbiol; 2005 Oct; 43(10):5384-7. PubMed ID: 16208025
[TBL] [Abstract][Full Text] [Related]
18. Daptomycin Resistance and Tolerance Due to Loss of Function in Staphylococcus aureus
Barros EM; Martin MJ; Selleck EM; Lebreton F; Sampaio JLM; Gilmore MS
Antimicrob Agents Chemother; 2019 Jan; 63(1):. PubMed ID: 30397055
[TBL] [Abstract][Full Text] [Related]
19. Serum bactericidal activities of high-dose daptomycin with and without coadministration of gentamicin against isolates of Staphylococcus aureus and Enterococcus species.
DeRyke CA; Sutherland C; Zhang B; Nicolau DP; Kuti JL
Antimicrob Agents Chemother; 2006 Nov; 50(11):3529-34. PubMed ID: 17065618
[TBL] [Abstract][Full Text] [Related]
20. Short-course gentamicin in combination with daptomycin or vancomycin against Staphylococcus aureus in an in vitro pharmacodynamic model with simulated endocardial vegetations.
Tsuji BT; Rybak MJ
Antimicrob Agents Chemother; 2005 Jul; 49(7):2735-45. PubMed ID: 15980344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
